Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

CONVERTIBLE DEBT AND EQUITY FINANCINGS (Tables)

6 Months Ended

Mar. 31, 2015

		As of March 31, 2015
Note Type and Investor	Due Date	Balance		Discount		Carrying Value
Senior Secured 5% Notes Convertible at $0.25 (the “September 2014 Notes”)		($)		($)		($)

RSJ Private Equity	03/21/2016	$	750,000	$	(44,600)	$	705,400
4 Accredited Investors	03/21/2016		300,000		(19,100)		280,900
John Pappajohn	03/21/2016		300,000		(23,300)		276,700
Tierney Family Trust	03/21/2016		415,000		(34,100)		380,900
Oman Ventures	03/21/2016		200,000		(16,900)		183,100
Follman Family Trust	03/21/2016		100,000		(6,300)		93,700
Total Secured Convertible Promissory (September 2014) Notes		$	2,065,000	$	(144,300)	$	1,920,700